Table 2 The demographic and clinical characteristics of ICB in PD patients
Variables | Control (n = 39) | Case (n = 52) |
|---|---|---|
Age | ||
Mean ± SE | 63.46 ± 1.344 | 62.42 ± 1.087 |
Median | 63.00 | 63.00 |
Range | 42 - 85 | 42 - 77 |
Duration of PD | ||
Mean ± SE | 5.77 ± 0.745 | 8.17 ± 0.725 |
Median | 4.00 | 8.00 |
Range | 1.0 - 20.0 | 0.0 - 23.0 |
Gender, n (%) | ||
Male | 27 (69) | 38 (73) |
Female | 12 (31) | 14 (27) |
Ethnicity, n (%) | ||
Malay | 13 (33) | 8 (15) |
Chinese | 25 (64) | 34 (66) |
Indian | 1 (3) | 8 (15) |
Others | 0 (0) | 2 (4) |
Drug Medication, n (%) | ||
No Medication | 4 (10) | 2 (4) |
Levadopa only | 15 (39) | 15 (29) |
Dopamine agonist only | 6 (15) | 7 (13) |
Levadopa + Dopamine agonist | 14 (36) | 28 (54) |
Dosage of Levadopa | ||
Mean ± SE | 172.79 ± 26.89 | 345.98 ± 41.53 |
Median | 150.00 | 150.00 |
Range | 0.00 - 675.00 | 0.00 - 675.00 |
Dosage of DA | ||
Mean ± SE | 1.05 ± 0.19 | 82.79 ± 12.16 |
Median | 1.00 | 80.00 |
Range | 0.00 - 5.00 | 0.00 - 360.00 |
Diagnosis, n (%) | ||
One repetitive behaviour | 0 (0) | 30 (57) |
>1 repetitive behaviour | 1 (3) | 15 (29) |
Compulsive medication | 1 (3) | 2 (4) |
>1 repetitive behaviour + Compulsive medication | 0 (0) | 5 (10) |
No repetitive behaviour + Compulsive medication | 37 (94) | 0 (0) |